search forPar Pharmaceutical Companies, Inc

Region
Status
goods and services
Instead search for Par Pharmaceutical Companies (12 Results)
Class(es)
EUIPO
544
02/21/2008
01/23/2009
02/21/2018
Registration expired
USPTO
39
03/10/2015
04/18/2017
-
REGISTERED
USPTO
542
11/17/2014
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
53542
11/17/2014
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
5
03/07/2014
11/04/2014
-
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
USPTO
542
08/22/2007
10/05/2010
-
REGISTERED AND RENEWED
USPTO
5
01/15/2009
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
5
01/15/2009
-
-
ABANDONED - AFTER INTER-PARTES DECISION
USPTO
5
12/05/2008
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
5
12/05/2008
-
-
ABANDONED - NO STATEMENT OF USE FILED

That’s Why a Free TMDB Account Is Worthwhile

Monitor and protect brands

If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.

Follow brands easily

If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.

Sign up for free
USPTO
5
11/20/2008
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
542
08/22/2007
10/05/2010
-
REGISTERED AND RENEWED

That’s Why a Free TMDB Account Is Worthwhile

Monitor and protect brands

If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.

Follow brands easily

If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.

Sign up for free

Search results 1 - 12 of 12

We love brands.
And are happy to look after you.

You can reach us from Monday to Friday between 08:00-16:00.

Kontaktieren Sie uns.